PharmiWeb.com - Global Pharma News & Resources
10-Aug-2021

Bioimpedance Devices Market Region Wise Analysis of Top Players, Upcoming Challenges, Global Insight 2028

Increasing cases of CKD diseases are expected to contribute to the growth of the Bioimpedance devices market throughout the forecast period. Chronic kidney disease (CKD) is a medical condition that can be characterized by gradual loss of kidney function over time. As per the National Kidney Foundation, Inc., 30 million American adults have chronic kidney disease and millions of others are at high risk of developing CKD. The Glomerular filtration rate (GFR) is the best overall index for studying kidney function. Bioelectrical impedance or Bioimpedance is used for improved estimation of glomerular filtration rate in non-diabetic patients with chronic kidney disease and also to estimate muscle mass. Bioelectrical impedance analysis (BIA) can also be used to measure appendicular lean mass (ALM). The performance of these equations that include ALM BIA to estimate renal inulin clearance (GFR INU) can be compared with demographic variables and further used for modifications in diet for renal disease (MDRD) treatment.

Widespread online marketing channels have tremendously increased the sale of portable as well as hand-held Bioimpedance devices in recent years. For Instance, a research study estimated that in 2015, approximately 70% of the population in the U.S. depended on online shopping portals for buying different items. Vendors operating in the Bioimpedance devices market are focusing on promotional strategies and online marketing to ensure better access to their devices and increase sales. Devices offered online also help vendors cut on operational and distribution costs. The online marketing channel also allows vendors to offer information about devices in their portfolio and gain access to both global and local markets. In addition, these online marketing websites provide a broad selection of high-quality Bioimpedance systems at more affordable costs.

Download Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5563

Key Point Deeply Analysed by Bioimpedance Devices Market Report:

  • North America, Europe, Asia Pacific, Middle East and Africa, Latin America Bioimpedance Devices market size including (sales, revenue and growth rate of industry).
  • Global major manufacturers’ operating situation (sales, revenue, growth rate and gross margin) of Bioimpedance Devices industry.
  • Different types and applications of Bioimpedance Devices industry, market share of each type and application by revenue.
  • Global market size (sales, revenue) forecast by regions and countries from 2020 to 2030 of Bioimpedance Devices Market.
  • Upstream raw materials and manufacturing equipment, industry chain analysis of Bioimpedance Devices industry.
  • SWOT analysis of Bioimpedance Devices Market.
  • New Project Investment Feasibility Analysis of Bioimpedance Devices Market Forecast.

Majority of the manufacturers in the Bioimpedance Devices makers are focusing on developing products that are portable and affordable. The popularity of portable Bioimpedance devices is increasing due to its various advantages. For instance, Bioimpedance Devices are noninvasive, reasonable, safe and easy to operate. These devices are light in weight and thus, are extensively used in home-based healthcare settings for monitoring health of the entire family. All these factors, cumulatively, are expected to drive the demand for portable Bioimpedance devices during the forecast period. Portable/ Hand-held Bioimpedance devices are also tremendously being opted by people for traveling purposes. For instance, the demand for ImpediMed SFB7, which is a hand-held Bioimpedance device, is increasing as this device is easy to carry. Technological advancements to enhance the quality of Bioimpedance devices and increase patient compliance are also projected to drive the growth of the market over the forecast period.

Multiple-frequency Bioimpedance Devices are highly preferred because these devices can measure impedances in various frequencies. This provides a better and efficient estimation of fat free mass, total body water and intra and extra cellular water. Single frequency Bioimpedance devices can calculate fat free mass and total body water but these devices are not capable of estimating intra and extra cellular body water. Increasing popularity and growing awareness about multiple-frequency Bioimpedance devices is expected to boost market growth for Bioimpedance devices over the forecast period.

FMI has segmented the global Bioimpedance Devices market by product type, modality and end user. The Bioimpedance Devices market, by product type, is segmented into Single-frequency Bioimpedance Devices and Multiple-frequency Bioimpedance Devices. By Modality, the Bioimpedance devices market is segmented into Wired Bioimpedance Devices and Wireless Bioimpedance Devices. Bioimpedance Devices, by end users, are segmented into Hospitals, Specialty Clinics, Rehabilitation Centers and Others. Region-wise segmentation includes North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. The wired Bioimpedance devices segment in the Bioimpedance Devices market is expected to witness a significant growth during the forecast period.

The report tracks some of the key companies operating in the Bioimpedance Devices market, including General Electric Company, Omron Corporation, Fresenius Medical Care, ImpediMed Limited, SELVAS AI Inc., Tanita Corporation, RJL Systems, Inc., Maltron International Ltd., Bodystat Limited and SMT Medical GmbH.

Request For TOC of Report @ https://www.futuremarketinsights.com/reports/bioimpedance-device-market/table-of-content

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

More from Healthcare, Pharmaceuticals and Medical devices Market Insights Market Intelligence:

  • Infusion Pumps Market – 2020 Analysis and Review: Infusion Pumps Market by Product – Syringe Pumps, Ambulatory Pumps, Volumetric Pumps, etc al for 2020-2030
  • Physiotherapy Equipment Market – 2020 Analysis and Review: Physiotherapy Equipment Market by Application – Neurological, Musculoskeletal, Cardiovascular & Pulmonary for 2020-2030

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

 For Media Enquiries: press@futuremarketinsights.com

Editor Details

Last Updated: 10-Aug-2021